Cargando…
A Gene Expression Signature for RSV: Clinical Implications and Limitations
Peter Openshaw discusses the challenges in advancing respiratory syncytial virus (RSV) treatments and the implications of a study by Mejias and colleagues using a newly identified gene signature for diagnosis and prediction of RSV severity. Please see later in the article for the Editors' Summa...
Autor principal: | Openshaw, Peter J. M. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Public Library of Science
2013
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3825653/ https://www.ncbi.nlm.nih.gov/pubmed/24265600 http://dx.doi.org/10.1371/journal.pmed.1001550 |
Ejemplares similares
-
Is it RSV?
por: Ambrose, Christopher S.
Publicado: (2018) -
Protective and dysregulated T cell immunity in RSV infection()
por: Openshaw, Peter J, et al.
Publicado: (2013) -
Immunity to RSV in Early-Life
por: Lambert, Laura, et al.
Publicado: (2014) -
Are There Limits in Explainability of Prognostic Biomarkers? Scrutinizing Biological Utility of Established Signatures
por: Emmert-Streib, Frank, et al.
Publicado: (2021) -
Challenges in Maximizing Impacts of Preventive Strategies against
Respiratory Syncytial Virus (RSV) Disease in Young Children
por: Zheng, Zhe
Publicado: (2022)